Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note Journal Article


Authors: Bilchik, A. J.; Poston, G.; Curley, S. A.; Strasberg, S.; Saltz, L.; Adam, R.; Nordlinger, B.; Rougier, P.; Rosen, L. S.
Article Title: Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note
Keywords: clinical trial; drug tolerability; review; bevacizumab; fluorouracil; multimodality cancer therapy; adjuvant therapy; postoperative care; chemotherapy, adjuvant; combined modality therapy; neoadjuvant therapy; cancer staging; antineoplastic agent; colorectal cancer; controlled clinical trial; multiple cycle treatment; randomized controlled trial; antineoplastic combined chemotherapy protocols; colonic neoplasms; practice guideline; pathology; cetuximab; irinotecan; liver metastasis; randomized controlled trials; folinic acid; colon cancer; adjuvant chemotherapy; colon tumor; preoperative treatment; oxaliplatin; fatty liver; vein occlusion; sinusoidal obstruction syndrome; practice guidelines
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 36
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-12-20
Start Page: 9073
End Page: 9078
Language: English
DOI: 10.1200/jco.2005.03.2334
PUBMED: 16361615
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 95" - "Export Date: 24 October 2012" - "CODEN: JCOND" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz